Recombinant Mouse Anti-M. tuberculosis ESAT6 Antibody (HYB076-08) (CAT#: MRO-282CQ)

This product is a mouse monoclonal antibody that specially recognizes M. tuberculosis ESAT6.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Datasheet
  • MSDS
  • COA
WB

Figure 1 Expression of the Mtb fusion proteins in A549 cells infected with MVATG18377.

Figure 1 Expression of the Mtb fusion proteins in A549 cells infected with MVATG18377.

RpfB-RpfD-Ag85B-TB10.4-ESAT-6 fusion (*, expected molecular weight: 87.0 kDa) was detected using mouse monoclonal anti-ESAT-6 HYB076-08 antibody.

A Novel MVA-Based Multiphasic Vaccine for Prevention or Treatment of Tuberculosis Induces Broad and Multifunctional Cell-Mediated Immunity in Mice and Primates

WB

Figure 2 The immunogenic components of RD1 are not expressed by the environmental mycobacteria M. avium, M. vaccae, and M. scrofulaceum.

Figure 2 The immunogenic components of RD1 are not expressed by the environmental mycobacteria M. avium, M. vaccae, and M. scrofulaceum.

Western blot analysis of antigens cross-reacting with an anti-ESAT-6 monoclonal antibody and with polyclonal anti-sera raised against CFP-10, PPE68 and Ag85B is shown.

Differential Effects of Prior Exposure to Environmental Mycobacteria on Vaccination with Mycobacterium bovis BCG or a Recombinant BCG Strain Expressing RD1 Antigens

Stim

Figure 3 Immunization with environmental mycobacteria generates cellular responses cross-reacting with the 30-kDa BCG antigen but not with ESAT-6.

Figure 3 Immunization with environmental mycobacteria generates cellular responses cross-reacting with the 30-kDa BCG antigen but not with ESAT-6.

Mycobacterium-specific IFN-γ production in mice (n = 3) infected with M. avium, M. scrofulaceum, M. vaccae, or a cocktail of the three strains (Mix) are compared. Splenocytes were stimulated in vitro with ₚESAT-6, Ag85B, or culture filtrate prepared from the relevant mycobacterial strain.

Differential Effects of Prior Exposure to Environmental Mycobacteria on Vaccination with Mycobacterium bovis BCG or a Recombinant BCG Strain Expressing RD1 Antigens

Stim

Figure 4 Specific cellular responses induced by BCG::RD1 vaccination are not altered by sensitization with environmental mycobacteria.

Figure 4 Specific cellular responses induced by BCG::RD1 vaccination are not altered by sensitization with environmental mycobacteria.

Mycobacterium-specific IFN-γ production in mice (n = 3) vaccinated with BCG::pYUB412 (BCG) or BCG::RD1 following sensitization with M. avium, M. scrofulaceum or M. vaccae is compared. Splenocytes were prepared 3 weeks postimmunization and stimulated in vitro with pESAT-6, Ag85B, or culture filtrates prepared from BCG or BCG::RD1 (BCG CF, BCG::RD1 CF).

Differential Effects of Prior Exposure to Environmental Mycobacteria on Vaccination with Mycobacterium bovis BCG or a Recombinant BCG Strain Expressing RD1 Antigens

WB

Figure 5 Secretion of antigenic proteins by Mycobacterium tuberculosis and M. africanum.

Figure 5 Secretion of antigenic proteins by Mycobacterium tuberculosis and M. africanum.

Immunoblot of ESAT-6, CFP-10, and Ag85 family members in the culture filtrate (CF), comparing H37Rv, M. africanum GM041182, and the M. africanum Rv3879c complemented strain.

Impaired Fitness of Mycobacterium africanum Despite Secretion of ESAT-6


Specifications

  • Immunogen
  • Mycobacterium tuberculosis
  • Host Species
  • Mouse
  • Derivation
  • Mouse
  • Type
  • IgG
  • Specificity
  • Mycobacterium tuberculosis ESAT6
  • Species Reactivity
  • M. tuberculosis
  • Clone
  • HYB076-08
  • Applications
  • ELISA
  • Related Disease
  • Tuberculosis

Product Property

  • Storage
  • Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples.

Applications

  • Application Notes
  • The EsxA antibody has been reported in applications of Enzyme-linked Immunosorbent Assay, Western Blot, Stimulation.

Target

  • Alternative Names
  • ESAT-6 protein EsxA; esxA; Rv3875; ESAT6; Early Secreted Antigenic Target Protein; M. tuberculosis; Mycobacterium tuberculosis

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "esxA"

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for MRO-282CQ. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare